Fundraising FoxChainFund Capital — 2019 Investments
4 investments dated 2019 · listed companies and verified rows first · show all
OncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity.
BiotechDeep TechHealthtechSeattle, US
Matt Scholz(Executive Officer, Director)John Lewis(Executive Officer, Director)inGary Hudson(Director)in
Co-investorsHelios CapitalMethuselah FoundationInvesco
Orbit Fab builds the in-space propellant supply chain, offering commercial spacecraft refueling services and standardized refueling interfaces to enable reusable spacecraft and a sustainable space economy.
HardwareSpace TechSanta Clara, US
Daniel Faber(Co-Founder)inJeremy Schiel(Executive Officer, Director)inPeter Shaper(CEO)inChingti Yang(Executive Officer)
Co-investors2045 VenturesACADEMY INVESTORAIN VenturesAsymmetry VenturesAurum Venture PartnersCapital Factory+20 more
Relativity Space develops Terran R, a reusable medium-to-heavy-lift rocket designed for efficiency and scalability, serving government entities, telecommunications companies, and commercial customers for space access missions.
Advanced ManufacturingAI & Machine LearningDeep TechDefense TechHardwareSpace TechLos Angeles, US
Tim Ellis(Founder/CEO)inJordan Noone(Executive Officer, Director, Promoter)inEric Schmidt(CEO)in
Co-investorsAidenlair CapitalARA NEA Ventures (Brand: Dmz.Xyz)Aurum Venture PartnersBalerion Space VenturesBaruch Future VenturesBold Capital Partners+59 more
Volumetric Biotechnologies, acquired by 3D Systems in 2021, develops bioprinting materials and vascularized human tissue constructs.
BiotechDeep TechHealthtechMedical DevicesHouston, US
Jordan Miller(Co-Founder and President)inBagrat Grigoryan(Co-Founder, COO)in
Co-investorsGoAhead VenturesHarmonix FundHelios CapitalJoyance PartnersJude GomilaMethuselah Foundation+21 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.